既往肠道菌群失调加剧小鼠蛛网膜下腔出血后神经炎症与血管痉挛
该研究在小鼠内皮穿孔法蛛网膜下腔出血(SAH)模型中,用广谱抗生素诱导既往肠道菌群失调(GMD),评估其是否加重SAH后神经炎症与血管痉挛。结果显示,SAH本身早期对肠道菌群影响很小,而既往GMD虽不影响初始SAH严重程度,却显著加重体重下降、神经功能缺损和脑血管痉挛,并伴中枢与外周免疫反应放大。
要点
- 既往GMD不影响初始SAH严重程度,但加重SAH后神经功能缺损与体重下降。
- GMD加重脑血管痉挛,痉挛程度与内皮ICAM-1及皮质IBA-1阳性小胶质细胞/巨噬细胞相关。
- GMD升高CCL5并降低G-CSF,CCL5水平与神经炎症和血管痉挛严重程度相关。
核心结论
- 既往GMD通过失调的中枢和全身免疫反应加重SAH后神经血管炎症、血管痉挛和神经功能损害。
- 研究提示肠脑轴是迟发性脑缺血样病理的关键调节因素,微生物组靶向策略可能成为SAH的潜在治疗方向。
研究设计与样本
- 雄性C57BL/6J小鼠接受广谱抗生素诱导肠道菌群清除或对照处理,随后行血管内穿孔法SAH或对照手术。
- 纵向评估神经功能、体重和死亡率;用大脑前动脉形态计量量化脑血管痉挛。
- 用ICAM-1和IBA-1免疫荧光评估内皮活化与神经炎症,流式细胞术分析脑和脾免疫细胞,多重检测测血清细胞因子,16S rRNA测序评估菌群组成。
主要发现
- 单纯SAH仅引起肠道微生物多样性或组成的轻微早期变化,提示SAH后早期结局并非由SAH诱导的菌群失调驱动。
- 既往GMD不影响初始SAH严重程度,但显著加重SAH后体重下降、神经功能缺损和脑血管痉挛。
- 血管痉挛严重程度与内皮ICAM-1表达及皮质IBA-1阳性小胶质细胞/巨噬细胞强相关。
- GMD放大中枢和外周炎症反应,表现为脑内CD86阳性巨噬细胞和中性粒细胞增多及脾脏巨噬细胞扩增。
- GMD改变全身细胞因子谱,CCL5升高、G-CSF降低,且CCL5水平与神经炎症和血管痉挛严重程度相关。
临床怎么用
- 结果支持在SAH研究中关注既往肠道菌群状态对神经血管炎症和血管痉挛的影响。
- CCL5等免疫介质可能作为反映神经炎症与血管痉挛严重程度的候选标志物。
- 微生物组靶向策略作为SAH治疗方向仍属临床前探索,尚不能直接用于临床决策。
局限性
- 证据来自雄性C57BL/6J小鼠的内皮穿孔SAH模型,结论外推至人类需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Delayed cerebral ischemia remains a major determinant of poor outcomes after aneurysmal subarachnoid hemorrhage (SAH), yet effective preventive strategies are limited. The gut-brain axis has emerged as an important modulator of post-SAH neuroinflammation and vascular dysfunction. We hypothesized that pre-existing gut microbiome dysbiosis (GMD) exacerbates neuroinflammation and vasospasm after SAH. METHODS: Male C57BL/6J mice underwent broad-spectrum antibiotic-induced gut microbiome depletion or control treatment, followed by endovascular perforation SAH or control surgery. Neurological function, body weight, and mortality were assessed longitudinally. Cerebral vasospasm was quantified by anterior cerebral artery morphometry. Endothelial activation and neuroinflammation were evaluated using intercellular adhesion molecule 1 and ionized calcium-binding adapter molecule 1 immunofluorescence. Immune cell populations in the brain and spleen were analyzed by flow cytometry, and serum cytokines were measured by multiplex assays. Gut microbiome composition was assessed using 16S rRNA sequencing in microbiota-intact mice. RESULTS: SAH alone caused minimal early changes in gut microbial diversity or composition, indicating that early post-SAH outcomes were not driven by SAH-induced dysbiosis. By contrast, pre-existing GMD did not affect initial SAH severity but significantly worsened post-SAH outcomes, including weight loss, neurological deficits, and cerebral vasospasm. Vasospasm severity correlated robustly with endothelial intercellular adhesion molecule 1 expression and cortical ionized calcium-binding adapter molecule 1-positive microglia/macrophages. GMD amplified central and peripheral inflammatory responses, characterized by increased CD86-positive macrophages and neutrophils in the brain and splenic macrophage expansion. Systemically, GMD altered cytokine profiles, with elevated CCL5 and reduced granulocyte colony-stimulating factor, and CCL5 levels correlated with both neuroinflammation and vasospasm severity. CONCLUSION: Pre-existing GMD exacerbates neurovascular inflammation, vasospasm, and neurological impairment after SAH through dysregulated central and systemic immune responses. These findings identify the gut-brain axis as a critical modulator of delayed cerebral ischemia-like pathology and suggest microbiome-targeted strategies as potential therapeutic approaches for SAH.
引用
- Matsukawa H, Fujita M, Kuramoto Y, et al. Pre-existing Gut Microbiome Dysbiosis Exacerbates Neuroinflammation and Vasospasm After Subarachnoid Hemorrhage in Mice. Neurosurgery. 2026. PMID: 42012190. doi:10.1227/neu.0000000000004035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。